P387 Persistence of antibodies to infliximab for more than two months strongly predicts loss of response to infliximab in inflammatory bowel diseases

Authors :: Xavier Roblin
J.M. Phelip
L Peyrin Biroulet
Stéphane Paul
E. Del Tedesco
Manon Leclerc
Hubert Marotte
P. Gonzalo
Source :: Journal of Crohn's and Colitis. 8:S226-S227
Publication Year :: 2014
Publisher :: Oxford University Press (OUP), 2014.

Subjects :: biology
business.industry
Gastroenterology
Inflammatory Bowel Diseases
General Medicine
medicine.disease
Inflammatory bowel disease
Infliximab
Persistence (computer science)
Antibodies to infliximab
Immunology
medicine
biology.protein
Antibody
business
medicine.drug

Full Text Access

Tools